 Balyasny Asset Management LLC purchased a new stake in shares of Amneal Pharmaceuticals Inc NYSE:AMRX during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 24,151 shares of the companys stock, valued at approximately 84,000. A number of other institutional investors also recently modified ... 